Critical Insights From Pacific Biosciences Analyst Ratings: What You Need To Know
Critical Insights From Pacific Biosciences Analyst Ratings: What You Need To Know
太平洋生物分析师评级的重要见解：你需要知道的
Providing a diverse range of perspectives from bullish to bearish, 11 analysts have published ratings on Pacific Biosciences (NASDAQ:PACB) in the last three months.
过去三个月里，11位分析师从看好到看淡提供了丰富的市场前景。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表总结了他们最近的评级，展示了过去30天内不断变化的情绪，并将其与前几个月进行了比较。
Analysts have set 12-month price targets for Pacific Biosciences, revealing an average target of $3.64, a high estimate of $8.00, and a low estimate of $2.00. A decline of 57.92% from the prior average price target is evident in the current average.
分析师们设定了太平洋生物科技公司(Pacific Biosciences)的12个月价格目标，显示出平均目标为3.64美元，最高估价为8.00美元，最低估价为2.00美元。相较前一个平均价格目标，这个目标下降了57.92%。
Diving into Analyst Ratings: An In-Depth Exploration
深入探讨分析师评级：分析师评级的深度探讨
The analysis of recent analyst actions sheds light...
最近分析师们的行...
登录免费看全文
登录/注册